Tag Archive for: board appointment

Blue Cell Therapeutics appoints leading cell therapy executive Miguel Forte MD, PhD, to its Board of Directors

/in

Miguel Forte, current President of the International Society for Cell & Gene Therapy (ISCT), joins Blue Cell as a Non-Executive Director Highly experienced executive with deep scientific expertise, who has helped lead numerous private and public cell therapy biotechs, establishing corporate structures and raising funds Appointment comes as Blue Cell advances its groundbreaking “off-the-shelf” allogeneic […]

Read more

Novo Holdings appoints four new members to its Board of Directors further strengthening global perspectives and strategic capabilities

/in

May 15, 2025 – Novo Holdings is pleased to announce the appointments of Jun Sung Kim, Lars Green, N.P. “Narv” Narvekar and Torsten Sløk to its Board of Directors, effective May 14, 2025. These distinguished leaders bring a broad range of investment expertise spanning both U.S. and international markets, further strengthening the Board’s global perspectives […]

Read more

Commit Biologics appoints accomplished R&D executive, Dr Janine Schuurman, to its Board of Directors

/in

Former senior vice president of antibody research at Genmab who has co-invented numerous FDA-approved therapeutic antibodies and as well as its DuoBody® bi-specific antibody platform. Brings decades of experience in developing strong pipelines of antibody-based drugs from platforms, growing scientific teams and managing partnerships with Pharma companies Appointment comes as Commit looks to progress towards […]

Read more

Novo Holdings leads $105 million financing of Magenta Medical to support FDA approval for world’s smallest heart pump

/in

Funds will be used to advance Magenta’s US clinical programs to support the FDA’s approval of the Elevate™ System, the world’s smallest heart pump Eric Snyder, Partner, Venture Investments, Novo Holdings will join Magenta Medical Board of Directors Boston, US, 23 July 2024 – Novo Holdings, a leading life science investor, today announces that it has […]

Read more

AMSilk strengthens management team with key hires of Ralph Fraundorfer and Ctibor Kohutovic to Management Board

/in

Neuried, Germany, 23 April 2024: AMSilk GmbH (“AMSilk”), a global leader in advanced materials made from spider silk-based proteins, today announces the appointments of Ralph Fraundorfer and Ctibor Kohutovic to its Management Board starting immediately. Read more…

Read more